Royalty Pharma plc

RPRX 10-K · FY 2025
API behind this page

RPRX FY 2025 request

Playground key active
Request URL /api/financials?ticker=RPRX&year=2025&quarter=4&full_year_mode=true
waiting 0 ms 
Pick an endpoint and run the request.
curl

Income Statement

JSON CSV Excel
Income Statement
Metric FY 2025 FY 2024 YoY
Revenue 2,378,193 2,263,576 +5.1%
Show Product Lines breakouts
Income from financial royalty assets 2,261,152 2,149,422 +5.2%
Other royalty income and revenues 117,041 114,154 +2.5%
Provision For Other Credit Losses -295,838 732,461 -140.4%
Provision For Credit Losses On Unfunded Commitments 89,032 — —
Research & Development 452,000 2,000 +22500.0%
Show Product Lines breakouts
Daraxonrasib 250 — —
General & Administrative 573,481 236,671 +142.3%
Total Costs & Expenses 818,675 971,132 -15.7%
Operating Income 1,559,518 1,292,444 +20.7%
Income Loss From Equity Method Investments -29,089 -29,611 +1.8%
Show Schedule Of Equity Method Investment Equity Method Investee Name breakouts
Avillion Entities -12.1 -19.2 +37.0%
Legacy Investors Partnerships -17 -10.4 -63.5%
Interest Expense 307,664 225,512 +36.4%
Equity Securities Fv Ni Unrealized Gain Loss 21,852 -39,549 +155.3%
Debt Securities Available For Sale Unrealized Gain Loss -45,859 -154,906 +70.4%
Interest Income Other -33,591 -47,343 +29.0%
Other Non-Operating Income (Expense) 14,349 1,528 +839.1%
Non-Operating Income (Expense) 235,326 -38,369 +713.3%
Income Before Taxes 1,324,192 1,330,813 -0.5%
Net Income 1,324,192 1,330,813 -0.5%
Show Equity Components breakouts
Noncontrolling Interest 553,245 471,830 +17.3%
Noncontrolling Interest · Continuing Investors Partnerships 231,260 276,893 -16.5%
Noncontrolling Interest · Founder's Equity 60,243 — —
Noncontrolling Interest · Legacy Investors Partnerships 232,524 194,937 +19.3%
Noncontrolling Interest · RP Holdings Class E Interests Holders 29,218 — —
Retained Earnings 770,947 858,983 -10.2%
Net Income Loss Attributable To Noncontrolling Interest 553,245 471,830 +17.3%
Show Counterparty Name breakouts
Continuing Investors Partnerships 231,260 276,893 -16.5%
Founder's Equity 60,243 — —
Legacy Investors Partnerships 232,524 194,937 +19.3%
RP Holdings Class E Interests Holders 29,218 — —
Show Title Of Individual breakouts
Chief Executive Officer · Equity Performance Awards 38.4 — —
Employees With Award Participation Prior To Internalization · Equity Performance Awards 21.8 — —
Show Award Type breakouts
Equity Performance Awards 60,243 — —
Net Income 770,947 858,983 -10.2%
EPS (Basic) 1.79 1.92 -6.8%
EPS (Diluted) 1.78 1.91 -6.8%
Wtd Avg Shares (Basic) 429,801 448,185 -4.1%
Wtd Avg Shares (Diluted) 564,455 594,108 -5.0%
Selling, General & Administrative (FY) — — —
Show Related Party Transaction breakouts
Operating and Personnel Payments · Related Party 115.7 188.6 -38.7%
Net Income Loss Available To Common Stockholders Basic 770,947 858,983 -10.2%

Balance Sheet

Balance Sheet
Metric FY 2025 FY 2024 YoY
Current Assets
Cash & Cash Equivalents 618,696 929,026 -33.4%
Notes And Loans Receivable Net Current 854,386 783,770 +9.0%
Available For Sale Securities Debt Securities Current 18,800 58,200 -67.7%
Show Fair Value Hierarchy breakouts
Fair Value Inputs Level3 · Debt Securities 18,800 58,200 -67.7%
Show Financial Instrument breakouts
Debt Securities 18,800 58,200 -67.7%
Debt Securities · Fair Value Measurements Recurring 18,800 58,200 -67.7%
Other Royalty Income Receivable Current 29,316 26,956 +8.8%
Other Assets Current 6,893 4,187 +64.6%
Total Current Assets 1,528,091 1,802,139 -15.2%
Non-Current Assets
Notes And Loans Receivable Net Noncurrent 16,208,482 15,127,158 +7.1%
Equity Securities F V N I Noncurrent 171,312 186,960 -8.4%
Show Fair Value Hierarchy breakouts
Fair Value Inputs Level1 · Fair Value Measurements Recurring 171,312 184,719 -7.3%
Show Fair Value By Measurement Frequency breakouts
Fair Value Measurements Recurring 171,312 186,960 -8.4%
Available For Sale Securities Debt Securities Noncurrent 419,000 693,500 -39.6%
Show Fair Value Hierarchy breakouts
Fair Value Inputs Level3 · Debt Securities 419,000 693,500 -39.6%
Show Financial Instrument breakouts
Debt Securities 419,000 693,500 -39.6%
Debt Securities · Fair Value Measurements Recurring 419,000 693,500 -39.6%
Goodwill 924,634 — —
Other Non-Current Assets 79,293 33,534 +136.5%
Total Assets 19,620,780 18,222,715 +7.7%
Operating Lease Right-of-Use Assets (Q) — — —
Show Business Acquisition breakouts
RP Manager 19.1 — —
Other Assets
Equity Method Investments 289,968 379,424 -23.6%
Current Liabilities
Distributions Payable To Non Controlling Interests Current 72,825 75,811 -3.9%
Show Counterparty Name breakouts
Founder's Equity · Related Party 6,733 — —
Legacy Investors Partnerships · Related Party 66,092 75,811 -12.8%
Accounts Payable And Accrued Liabilities Current 19,404 13,370 +45.1%
Interest Payable Current 110,818 98,062 +13.0%
Current Portion of Long-Term Debt 380,000 997,773 -61.9%
Other Liabilities Current 53,164 68,600 -22.5%
Total Current Liabilities 636,211 1,253,616 -49.2%
Non-Current Liabilities
Long-Term Debt 8,570,917 6,614,653 +29.6%
Accounts Payable And Accrued Liabilities Noncurrent 577,870 — —
Other Non-Current Liabilities 120,843 12,080 +900.4%
Total Liabilities 9,905,841 7,880,349 +25.7%
Long-Term Debt 8,950,917 7,612,426 +17.6%
Stockholders' Equity
Common Stock (Q) — — —
Show Statement Class Of Stock breakouts
Class R Redeemable Shares 63 63 0.0%
Common Class A 43 45 -4.4%
Additional Paid-In Capital 4,123,088 4,103,482 +0.5%
Retained Earnings 2,356,318 2,845,653 -17.2%
Minority Interest 3,238,039 3,395,785 -4.6%
Treasury Stock Common Value -2,612 -2,662 +1.9%
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 9,714,939 10,342,366 -6.1%
Show Equity Components breakouts
Additional Paid In Capital 4,123,088 4,103,482 +0.5%
Common Stock · Class R Redeemable Shares 63 63 0.0%
Common Stock · Common Class A 43 45 -4.4%
Noncontrolling Interest 3,238,039 3,395,785 -4.6%
Noncontrolling Interest · Continuing Investors Partnerships 1,799,783 2,207,445 -18.5%
Noncontrolling Interest · Legacy Investors Partnerships 1,083,319 1,188,340 -8.8%
Noncontrolling Interest · RP Holdings Class E Interests Holders 354,937 — —
Retained Earnings 2,356,318 2,845,653 -17.2%
Treasury Stock Common -2,612 -2,662 +1.9%
Treasury Stock Common · Acquisition Of Limited Partnership Interests In Affiliate 4.3 — —
Total Liabilities & Equity 19,620,780 18,222,715 +7.7%

Cash Flow Statement

Cash Flow Statement
Metric FY 2025 FY 2024 YoY
Operating Activities
Proceeds From Cash Collections From Royalties Received On Financing Receivables 3,354,750 2,983,410 +12.4%
Proceeds From Cash Collections From Royalties Received On Intangible Assets 720 14,647 -95.1%
Proceeds From Cash Collections From Other Royalties Received On Financing Receivables 114,021 108,846 +4.8%
Equity Method Investment Dividends Or Distributions 13,396 13,396 0.0%
Show Schedule Of Equity Method Investment Equity Method Investee Name breakouts
Avillion I 13.4 13.4 0.0%
Avillion II 3 1 +200.0%
Proceeds From Interest Received 34,308 46,482 -26.2%
Payments For Development Stage Funding -452,000 -2,000 -22500.0%
Payments For Operating Costs And Professional Services -288,138 -236,225 -22.0%
Payments For Employee Equity Performance Awards -10,943 — —
Interest Paid -276,291 -159,570 -73.1%
Net Cash from Operations 2,489,823 2,768,986 -10.1%
Stock-Based Compensation 289,894 2,344 +12267.5%
Other Non-Cash Items 13,307 1,105 +1104.3%
Investing Activities
Payments To Acquire Businesses Net Of Cash Acquired -74,416 — —
Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital 105,149 23,641 +344.8%
Show Schedule Of Equity Method Investment Equity Method Investee Name breakouts
Legacy Investors Partnerships 74.8 22.7 +229.5%
Payments To Acquire Equity Securities F N N I -58,427 -62,500 +6.5%
Proceeds Equity Securities 34,723 98,575 -64.8%
Purchases of Investments -175,000 -150,000 -16.7%
Proceeds From Sale Of Available For Sale Securities Debt 21,226 19,786 +7.3%
Proceeds From Additional Sales Of Available For Sale Debt Securities 510,553 — —
Payments To Acquire Finance Receivables -1,697,729 -2,505,701 +32.2%
Payments For Milestones -271,313 -75,000 -261.8%
Other Investing Activities -8,946 2,039 -538.7%
Net Cash from Investing -1,614,180 -2,678,115 +39.7%
Financing Activities
Payments To Noncontrolling Interests Portfolio Receipts -354,901 -362,280 +2.0%
Payments To Minority Shareholders -167,475 -125,159 -33.8%
Payment Of Dividends To Shareholders -378,253 -376,465 -0.5%
Share Repurchases -1,227,383 -229,651 -434.5%
Proceeds From Noncontrolling Interests Research And Development 220 747 -70.5%
Proceeds From Noncontrolling Interests Other 5,697 4,360 +30.7%
Proceeds From Long Term Lines Of Credit 1,275,000 — —
Repayments Of Lines Of Credit -1,275,000 — —
Repayments Of Other Long Term Debt -1,000,000 — —
Proceeds From Issuance Of Other Long Term Debt 1,954,475 1,471,235 +32.8%
Debt Issuance Costs -16,563 -12,616 -31.3%
Proceeds From Payments For Other Financing Activities -1,790 -9,026 +80.2%
Net Cash from Financing -1,185,973 361,145 -428.4%
Other Cash Flow
Net Change in Cash -310,330 452,016 -168.7%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 618,696 929,026 -33.4%

Values in thousands USD. Source: SEC EDGAR 10-K filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key